Multiple Sclerosis Clinical Trial

Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis

Summary

The primary objective is to evaluate the feasibility of the Multiple Sclerosis Performance Test (MSPT) in a clinical care setting when used by participants with Multiple Sclerosis (MS).

View Eligibility Criteria

Eligibility Criteria

Key Inclusion Criteria:

Ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to use confidential health information in accordance with applicable participant privacy regulations
Diagnosis of MS, including Clinically Isolated Syndrome
Ability to understand the audio and visual instructions for the test modules
Visual function, based on the investigator's clinical judgement that does not preclude an ability to interact with the Multiple Sclerosis Performance Test (MSPT).

Key Exclusion Criteria:

Unable or unwilling to provide informed consent
Participants younger than 18 years of age, unless their parent or legal guardian provides the required signed and dated informed consent and authorization to use confidential health information and the participant provides assent in accordance with national and local subject privacy regulations

NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

3073

Study ID:

NCT03926637

Recruitment Status:

Terminated

Sponsor:

Biogen

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 33 Locations for this study

See Locations Near You

Research Site
Berkeley California, 94705, United States
Research Site
Los Angeles California, 90033, United States
Research Site
Aurora Colorado, 80045, United States
Research Site
Washington District of Columbia, 20007, United States
Research Site
Atlanta Georgia, 30309, United States
Research Site
Atlanta Georgia, 30327, United States
Research Site
Chicago Illinois, 60008, United States
Research Site
Boston Massachusetts, 02215, United States
Research Site
Farmington Hills Michigan, 48334, United States
Research Site
Owosso Michigan, 48867, United States
Research Site
Saint Louis Missouri, 63131, United States
Research Site
Teaneck New Jersey, 07666, United States
Research Site
Buffalo New York, 14202, United States
Research Site
Durham North Carolina, 27710, United States
Research Site
Oklahoma City Oklahoma, 73104, United States
Research Site
Portland Oregon, 97225, United States
Research Site
Philadelphia Pennsylvania, 19104, United States
Research Site
Pittsburgh Pennsylvania, 15212, United States
Research Site
Dallas Texas, 75390, United States
Research Site
Salt Lake City Utah, 84103, United States
Research Site
Seattle Washington, 98122, United States
Research Site
Spokane Washington, 99208, United States
Research Site
Prague , 12000, Czechia
Research Site
Strasbourg , 67200, France
Research Site
Bari , 70124, Italy
Research Site
Catania , 95123, Italy
Research Site
Milano , 20132, Italy
Research Site
Orbassano , 10043, Italy
Research Site
Roma , 00185, Italy
Research Site
Basel , 4031, Switzerland
Research Site
Bern , 3010, Switzerland
Research Site
Camberley , GU16 , United Kingdom
Research Site
Oxford , OX3 9, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

3073

Study ID:

NCT03926637

Recruitment Status:

Terminated

Sponsor:


Biogen

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.